ACTOR robot recipient of R&D 100 award for 2002

ACTOR robot recipient of R&D 100 award for 2002

The Woodlands, TX — August 15, 2002. Rigaku is pleased to announce that ACTOR, the world's first commercial robotic system for automated sample handling, was named winner of a 2002 R&D 100 award, which has been called the Nobel Prizes of applied research. The 40th annual competition saw entries from many of the most prestigious companies, research organizations, and universities in the world.

Rigaku licensed ACTOR, the proven crystal transport, orientation and retrieval technology, from a major American pharmaceutical company. In conjunction with OSS (the designer of the crystal manipulation robot for NASA and the International Space Station), Rigaku refined the design and function of ACTOR. With its associated sample manipulation and storage tools and automated sample-evaluation and ranking software, ACTOR is a complete system designed to increase productivity and allow for unattended sample analysis for the high-throughput crystallography (HTC) labs of today. ACTOR eliminates many of the time consuming sample manipulation tasks previously required for routine crystal screening and data collection. HTC, once the wave of the future, is available today from Rigaku.

Astex Technology, Ltd, a British structure-based drug discovery company pioneering the use of HTC technology for the rapid identification of novel drug candidates, reported the successful collection and subsequent analysis and interpretation of 53 datasets in 3.5 days in a home laboratory using ACTOR and other instrumentation from Rigaku. Dr. Andrew J. Sharff of Astex said, "Based on a standard working day/week, this represents an increase in throughput of over 3 fold, compared to manual data collection".

Rigaku—Leading With Innovation

Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on life sciences and general purpose analytical instrumentation. With hundreds of major innovations to their credit, Rigaku companies are world leaders in the fields of small molecule and protein crystallography, X-ray spectrometry and diffraction, X-ray optics, as well as semiconductor metrology. Rigaku employs over 1,100 people in the manufacture and support of its analytical equipment. Its products are in use in more than 70 countries—supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial community.

For further information, contact:

Joseph D. Ferrara, Ph.D.
VP Product Marketing and CSO
Rigaku Americas Corporation
Tel: (281) 362-2300
eMail: joseph.ferrara@rigaku.com